Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume

Transforming growth factor β (TGF‐β) is thought to play an important role in bone metabolism, but its relationship to human bone turnover and bone mass has not been examined yet. In this study, we measured the concentration of TGF‐β in 811 samples of male and female bone from four representative sites of the human skeleton and in the supernatants of 72 short‐term human bone marrow cultures from the iliac crest. The concentrations of TGF‐β1 and TGF‐β2 in the bone matrix were positively correlated with histomorphometric indices of bone resorption and bone formation and with serum levels of osteocalcin and bone‐specific alkaline phosphatase. We also observed a positive association between the release of TGF‐β in the bone marrow cultures and serum osteocalcin. Changes in the rate of cancellous or cortical bone remodeling with age or menopause were accompanied by corresponding changes in skeletal TGF‐β. In contrast, there was no significant relationship between the concentration of TGF‐β and bone volume at any skeletal site. In conclusion, our study supports the hypothesis that TGF‐β plays an important role in human bone remodeling, but fails to demonstrate an association between the skeletal concentration of TGF‐β and human bone mass.

[1]  S. Cummings,et al.  Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures , 1996 .

[2]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[3]  S. Mohan,et al.  Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. , 1994, The Journal of clinical endocrinology and metabolism.

[4]  B. Riggs,et al.  Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone , 1991 .

[5]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[6]  L. Demers,et al.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[8]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  R. Ziegler,et al.  Circulating levels of midregional parathyroid hormone‐related protein in hypercalcaemia of malignancy , 1992, Clinical endocrinology.

[11]  L. Mosekilde,et al.  Age- and sex-related changes in iliac cortical bone mass and remodeling. , 1993, Bone.

[12]  J Dequeker,et al.  Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. , 1993, Arthritis and rheumatism.

[13]  R. Ziegler,et al.  Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. , 1995, The Journal of clinical endocrinology and metabolism.

[14]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[15]  T. Flynn,et al.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Cummings,et al.  Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. , 1996, JAMA.

[17]  B. Riggs,et al.  Osteoclasts and transforming growth factor-beta: estrogen-mediated isoform-specific regulation of production. , 1996, Endocrinology.

[18]  R. Ziegler,et al.  Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Ziegler,et al.  Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. , 1995, The Journal of clinical investigation.

[20]  A. Fontana,et al.  Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor / transforming growth factor (TGF)-β2 gene reveals striking differences to the TGF-β1 and -β3 genes , 1990 .

[21]  D. Kiel,et al.  Bone mass and the risk of breast cancer among postmenopausal women. , 1997, The New England journal of medicine.